Insider Transactions Reported by 12 Insiders of ONCOLYTICS BIOTECH INC

Symbol
ONCY on Nasdaq
Location
Calgary

Insiders trading volume in the past year

ONCOLYTICS BIOTECH INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bernd R. Seizinger Director $480,014 +$187,224 +64% 11 Feb 2026
Wayne Pisano Director $415,892 +$25,338 +6.5% 12 Feb 2026
Kirk Look Chief Financial Officer $242,087 +$10,104 +4.4% 12 Feb 2026
Thomas Charles Heineman Chief Medical Officer $233,890 +$10,033 +4.5% 12 Feb 2026
Angela Holtham Director $190,984 01 Jan 2026
Allison Hagerman VP, Product Development $95,475 +$8,298 +9.5% 12 Feb 2026
Deborah Margaret Brown Director $93,329 +$21,240 +29% 12 Feb 2026
Jared Kelly Chief Executive Officer, Director $91,778 +$29,521 +47% 11 Feb 2026
Patricia S. Andrews Director $66,854 +$30,292 +83% 12 Feb 2026
Andrew Aromando Chief Business Officer $47,314 +$25,418 +116% 11 Feb 2026
JONATHAN RIGBY Director $44,437 01 Jan 2026
Parsons James T. Director $33,122 01 Jan 2026

Recent Insider Transactions by Companies or Individuals for ONCOLYTICS BIOTECH INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.